- Home
- TOMZ vs CVKD Comparison
TOMZ vs CVKD Comparison
Compare TOMZ & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | CVKD |
|---|---|---|
| Founded | 1979 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 19.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | CVKD |
|---|---|---|
| Price | $0.80 | $9.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 22.5K | 18.1K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,688,341.00 | N/A |
| Revenue This Year | $18.31 | N/A |
| Revenue Next Year | $103.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $8.74 |
| 52 Week High | $1.50 | $22.90 |
Technical Indicators
Market Signals| Indicator | TOMZ | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 27.16 |
| Support Level | $0.76 | $9.30 |
| Resistance Level | $0.85 | $11.29 |
| Average True Range (ATR) | 0.05 | 0.81 |
| MACD | 0.00 | -0.24 |
| Stochastic Oscillator | 43.48 | 2.43 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.